John M. Evans - Jul 28, 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
CEO, Director
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Jul 28, 2022
Transactions value $
-$3,288,081
Form type
4
Date filed
7/29/2022, 04:06 PM
Previous filing
Jun 13, 2022
Next filing
Nov 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Sale -$660K -10.2K -0.91% $64.87 1.11M Jul 28, 2022 Direct F1, F2
transaction BEAM Common Stock Sale -$1M -15.2K -1.37% $65.82 1.09M Jul 28, 2022 Direct F1, F3
transaction BEAM Common Stock Sale -$104K -1.56K -0.14% $66.74 1.09M Jul 28, 2022 Direct F1, F4
transaction BEAM Common Stock Sale -$193K -2.85K -0.26% $67.80 1.09M Jul 28, 2022 Direct F1, F5
transaction BEAM Common Stock Sale -$11.8K -173 -0.02% $68.49 1.09M Jul 28, 2022 Direct F1
transaction BEAM Common Stock Sale -$451K -6.95K -4.86% $64.88 136K Jul 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F6
transaction BEAM Common Stock Sale -$699K -10.6K -7.79% $65.92 125K Jul 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F7
transaction BEAM Common Stock Sale -$13.4K -201 -0.16% $66.61 125K Jul 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F8
transaction BEAM Common Stock Sale -$152K -2.25K -1.79% $67.82 123K Jul 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.42, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.43 to $66.34, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.44 to $67.37, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.45 to $67.87, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.38, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.46 to $66.45, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.50 to $66.61, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.72 to $68.49, inclusive.